Omeros Corp (OMER) is near the top in its industry group according to InvestorsObserver. OMER gets an overall rating of 61. That means it scores higher than 61 percent of stocks. Omeros Corp gets a 84 rank in the Biotechnology industry. Biotechnology is number 81 out of 148 industries.
OMER has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on OMER!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 61 means the stock is more attractive than 61 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Omeros Corp Stock Today?
Omeros Corp (OMER) stock is lower by -39.21% while the S&P 500 is up 1.01% as of 12:07 PM on Monday, Oct 16. OMER is lower by -$0.89 from the previous closing price of $2.27 on volume of 4,872,410 shares. Over the past year the S&P 500 is higher by 18.86% while OMER is lower by -58.43%. OMER earned $0.64 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 2.15.
Click Here to get the full Stock Report for Omeros Corp stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
